Kizzmekia emphasizes the importance of trusting the FDA's rigorous review process for vaccines, especially in the context of a pandemic where lives are at stake. She acknowledges the roots of public distrust, particularly stemming from past decisions like the emergency use authorization of hydroxychloroquine. The conversation highlights the ongoing need for transparency and trustworthiness from health institutions as they navigate the complexities of vaccine distribution and safety.
